Roundtable Discussion: Leveraging AI Platforms to Predict Optimal Antigens & Accelerate Translational ASIT Development
- Applying AI to predict the most suitable antigens for immune tolerance, potentially accelerating discovery and improving target selection
- Many AI platforms exist, but validation of predicted antigens is still limited, and false leads remain a challenge
- Explore novel approaches, integrate new technologies, and refine predictive models for translational applications